Marshall Wace
SFE

Marshall Wace’s Safeguard Scientifics, Inc. SFE Stock Holding History

Marshall Wace’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,749
Closed -$99K – 2167
2019
Q3 		$99K Buy
+8,749
New +$104K ﹤0.01% 1397

Other funds holding SFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Horton Capital Management Philadelphia, Pennsylvania $44.9M AUM 24.87% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Marshall Wace's SFE Position: Q4 2019 in Review

Marshall Wace sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2019, closing a stake of 8,749 shares — an estimated $99K sold.

Marshall Wace first reported a position in SFE in Q3 2019 and held it in 1 quarter. The position peaked at $99K in Q3 2019. 91 funds tracked by Wall St. Rank hold SFE as of Q4 2019.

  • Marshall Wace reported no remaining Safeguard Scientifics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace sold 8,749 Safeguard Scientifics, Inc. shares in Q4 2019, an estimated $99K.
  • Marshall Wace first reported a position in Safeguard Scientifics, Inc. in Q3 2019 and held it in 1 quarter.
  • Marshall Wace's Safeguard Scientifics, Inc. position peaked at $99K in Q3 2019.
  • 91 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2019.

Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.